Related references
Note: Only part of the references are listed.Therapeutic Vaccination against the Rhesus Lymphocryptovirus EBNA-1 Homologue, rhEBNA-1, Elicits T Cell Responses to Novel Epitopes in Rhesus Macaques
Eduardo L. V. Silveira et al.
JOURNAL OF VIROLOGY (2013)
CD4+ and CD8+ T-Cell Responses to Latent Antigen EBNA-1 and Lytic Antigen BZLF-1 during Persistent Lymphocryptovirus Infection of Rhesus Macaques
R. M. Leskowitz et al.
JOURNAL OF VIROLOGY (2013)
Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
Corey Smith et al.
CANCER RESEARCH (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Contributions of Epstein-Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Lori Frappier
VIRUSES-BASEL (2012)
Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis-Association and Causation
Andreas Lossius et al.
VIRUSES-BASEL (2012)
Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1
Judy T. Tellam et al.
PLOS PATHOGENS (2012)
An Epstein-Barr Virus Encoded Inhibitor of Colony Stimulating Factor-1 Signaling Is an Important Determinant for Acute and Persistent EBV Infection
Makoto Ohashi et al.
PLOS PATHOGENS (2012)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
EBV Latency Types Adopt Alternative Chromatin Conformations
Italo Tempera et al.
PLOS PATHOGENS (2011)
The prevalence and prevention of nasopharyngeal carcinoma in China
Su-Mei Cao et al.
Chinese Journal of Cancer (2011)
Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders
Kimberley Jones et al.
BLOOD (2010)
Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway
Lauren DiMenna et al.
JOURNAL OF IMMUNOLOGY (2010)
Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
Chrystal U. Louis et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Herpes Simplex Virus Glycoprotein D Interferes with Binding of Herpesvirus Entry Mediator to Its Ligands through Downregulation and Direct Competition
Katie M. Stiles et al.
JOURNAL OF VIROLOGY (2010)
Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae
H. Chen et al.
JOURNAL OF VIROLOGY (2010)
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
Dongming Zhou et al.
NATURE PROTOCOLS (2010)
Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-γ T cell responses
Ann M. Moormann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens
Nia Tatsis et al.
JOURNAL OF IMMUNOLOGY (2009)
New Insights on Adenovirus as Vaccine Vectors
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2009)
Decreased EBNA-1-specific CD8+T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma
Mark H. Fogg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Patients with Epstein Barr virus-positive lymphomas have decreased CD4+ T-cell responses to the viral nuclear antigen 1
Kevin N. Heller et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets:: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines
Tracey A. Haigh et al.
JOURNAL OF IMMUNOLOGY (2008)
Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses
Marcio O. Lasaro et al.
NATURE MEDICINE (2008)
CD8 T cell dysfunction during chronic viral infection
Haina Shin et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
Zhiquan Xiang et al.
EMERGING INFECTIOUS DISEASES (2006)
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma
E Piriou et al.
BLOOD (2005)
The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue
MH Fogg et al.
JOURNAL OF VIROLOGY (2005)
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity
NH Gudgeon et al.
JOURNAL OF VIROLOGY (2005)
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
HM Long et al.
JOURNAL OF VIROLOGY (2005)
The human T cell immune response to Epstein-Barr virus
E Landais et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2005)
Mechanisms of disease - Persistence of the Epstein-Barr virus and the origins of associated lymphomas
DA Thorley-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host
P Rivailler et al.
BLOOD (2004)
Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes
A Reyes-Sandoval et al.
JOURNAL OF VIROLOGY (2004)
CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
SP Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers
AR Pinto et al.
JOURNAL OF IMMUNOLOGY (2003)
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface
SA Connolly et al.
JOURNAL OF VIROLOGY (2003)
A simian replication-defective vaccine to HIV-1 gag
JC Fitzgerald et al.
JOURNAL OF IMMUNOLOGY (2003)
Cytolytic CD4(+)-T-Cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-Cell proliferation
S Nikiforow et al.
JOURNAL OF VIROLOGY (2003)
Epstein-Barr nuclear antigen 1-specific CD4+ Th1 cells kill Burkitt's lymphoma cells
C Paludan et al.
JOURNAL OF IMMUNOLOGY (2002)
Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures
Q Sun et al.
BLOOD (2002)
Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells
A Khanolkar et al.
VIROLOGY (2001)
Epstein-Barr virus infection.
JI Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The decreased replicative capacity of simian immunodeficiency virus SIVmac239 Delta nef is manifest in cultures of immature dendritic cells and T cells
D Messmer et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
